“The mushroom was more alive and vibrant”: Patient reports of synthetic versus organic forms of psilocybin
Journal of Psychedelic Studies October 29, 2024 Pamela Kryskow, Paul Stamets, Joseph T. la Torre et al. 4 citations
Abstract Interest in psychedelic research in the West is surging, however, clinical trials have almost exclusively studied synthetic compounds such as MDMA, ketamine, DMT, LSD, ibogaine, and psilocybin. To date, few clinical trials have utilized whole mushroom/plant material like Psilocybe mushrooms, Iboga, or Ayahuasca. Individuals participating in the Roots To Thrive Psilocybin-Assisted...